Latest Regulatory News

Page 604 of 910
Memphasys Limited pivots from development to commercial execution with its flagship IVF product Felix, targeting global markets through direct sales and recurring revenue streams.
Ada Torres
Ada Torres
8 Aug 2025
Magnetite Mines Limited has announced a pro rata renounceable rights issue aiming to raise up to $2.65 million to advance its flagship Razorback iron ore project. The capital raise includes free attaching options and is partially underwritten, supporting key development milestones and strategic partnerships.
Maxwell Dee
Maxwell Dee
8 Aug 2025
Rewardle Holdings Limited reported a 2.8% revenue increase to $9.68 million for FY24 but swung to a $3.44 million net loss, driven by rising expenses and associate losses. The company expanded its footprint with acquisitions in grocery delivery and fintech, while deepening its stake in AI-powered health tech partner CloudHolter.
Sophie Babbage
Sophie Babbage
8 Aug 2025
Magnetite Mines Limited has updated its Razorback Iron Ore Project, revealing a 6.6 billion tonne mineral resource and progressing key strategic partnerships and approvals to support green steelmaking ambitions.
Maxwell Dee
Maxwell Dee
8 Aug 2025
Magnetite Mines Limited has announced a renounceable rights issue to raise up to $2.65 million, aiming to fund critical development milestones for its Razorback Iron Ore Project and secure strategic partnerships for DFS funding.
Maxwell Dee
Maxwell Dee
8 Aug 2025
Thunderbird Resources has addressed a recent spike in its share price and volume by releasing previously undisclosed survey results following a trading halt, reaffirming its compliance with ASX rules.
Maxwell Dee
Maxwell Dee
8 Aug 2025
Elders Limited faces a regulatory delay from the ACCC on its acquisition of Delta Agribusiness but remains optimistic about the deal's benefits and completion timeline.
Ada Torres
Ada Torres
8 Aug 2025
Neuren Pharmaceuticals has added SYNGAP1-related disorder to its NNZ-2591 development program following encouraging pre-clinical findings, targeting a rare condition with no approved treatments.
Ada Torres
Ada Torres
8 Aug 2025
PYC Therapeutics has escalated dosing to the highest level in its Phase 1a trial of PYC-003 and begun dosing patients with Polycystic Kidney Disease, marking key progress toward regulatory milestones.
Ada Torres
Ada Torres
8 Aug 2025
Piedmont Lithium reported strong Q2 2025 operational results with record production at North American Lithium and $11.9 million revenue, while shareholder voting on its merger with Sayona Mining has been adjourned to August 11.
Maxwell Dee
Maxwell Dee
8 Aug 2025
Kinterra Capital GP Corp. II has extended its takeover offer for New World Resources Limited, pushing the deadline to August 22, 2025. This marks the sixth extension in the ongoing bid process.
Maxwell Dee
Maxwell Dee
8 Aug 2025
Pinnacle Minerals Limited has launched a new options prospectus offering nearly 40 million options, potentially raising $3.18 million if exercised. The options carry an exercise price of $0.08 and expire in 2028, aiming to reward shareholders and fulfill placement obligations.
Maxwell Dee
Maxwell Dee
8 Aug 2025